Why pharmaceutical manufacturing can't afford IT failures: A real-world CDMO case study
The margin for error is extremely low in a critical sector like manufacturing, where accuracy, efficiency, and time to delivery are indispensable. These aspects become even more crucial in pharmaceutical manufacturing, a critical sector that is always in high demand, especially following the COVID-19 pandemic. The responsibility now falls on contract development and manufacturing organizations (CDMOs) that partner with pharmaceutical and biotech companies.